3D-segmentation of the 18F-choline PET signal for target volume definition in radiation therapy of the prostate. (Q51924755)

17 April 2018

title

3D-segmentation of the 18F-choline PET signal for target volume definition in radiation therapy of the prostate. (English)

1 reference

17 April 2018

adaptive radiation therapy

main subject

0 references

author name string

I Frank Ciernik

1

1 reference

17 April 2018

Derek W Brown

2

1 reference

17 April 2018

Daniel Schmid

3

1 reference

17 April 2018

Thomas Hany

4

1 reference

17 April 2018

Peter Egli

5

1 reference

17 April 2018

J Bernard Davis

6

1 reference

17 April 2018

publication date

1 February 2007

1 reference

17 April 2018

Technology in Cancer Research and Treatment

published in

1 reference

17 April 2018

volume

6

1 reference

17 April 2018

issue

1

1 reference

17 April 2018

page(s)

23-30

1 reference

17 April 2018

Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Automated functional image-guided radiation treatment planning for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

The reasons for discrepancies in target volume delineation : a SASRO study on head-and-neck and prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Defining a radiotherapy target with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

SPECT volume quantitation: influence of spatial resolution, source size and shape, and voxel size

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Positron emission tomography for prostate, bladder, and renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Lymph node staging in prostatic carcinoma revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Fluorocholine PET/CT in patients with prostate cancer: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Nuclear medicine techniques for the diagnosis and therapy of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of clinically advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

21 January 2018

PET and prostate cancer

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: accuracy, reproducibility and consistency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153303460700600104

10.1177/153303460700600104

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018